Naltrexone-bupropion combination therapy for protracted abstinence dysphoria

被引：2
|
作者：
Williams, J
Ziedonis, DM
机构：
[1] UMDNJ, Robert Wood Johnson Med Sch, SPH, Tobacco Dependence Program,Div Addict Psychiat, New Brunswick, NJ 08901 USA
[2] UMDNJ, Robert Wood Johnson Med Sch, Dept Psychiat, New Brunswick, NJ 08901 USA
来源：
AMERICAN JOURNAL ON ADDICTIONS | 2003年 / 12卷 / 03期
关键词：
D O I：
10.1080/10550490390203225
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：270 / 272
页数：3
相关论文
共 50 条
  • [1] Naltrexone-bupropion for weight loss
    Thomas, Betsy
    Lindblad, Adrienne J.
    Luu, Thao
    Paige, Allison
    CANADIAN FAMILY PHYSICIAN, 2023, 69 (09) : 627 - 627
  • [2] Combination therapy with naltrexone and bupropion for obesity
    Billes, Sonja K.
    Greenway, Frank L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (11) : 1813 - 1826
  • [3] Oral naltrexone-bupropion combination pharmacotherapy for methamphetamine use disorder: Pilot study protocol
    Moller, Carl I.
    Siefried, Krista J.
    Clifford, Brendan
    Acheson, Liam S.
    Brett, Jonathan
    Dunlop, Adrian J.
    Haber, Paul S.
    Christmass, Michael
    Lintzeris, Nicholas
    Morley, Kirsten
    Shoptaw, Steve
    Trivedi, Madhukar
    Ezard, Nadine
    DRUG AND ALCOHOL REVIEW, 2023, 42 : S121 - S122
  • [4] Evaluation of the Cardiovascular Risk of Naltrexone-Bupropion A Study Interrupted
    Sharfstein, Joshua M.
    Psaty, Bruce M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (10): : 984 - 986
  • [5] The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy
    le Roux, Carel W.
    Fils-Aime, Nadege
    Camacho, Fernando
    Gould, Errol
    Barakat, Maxime
    ECLINICALMEDICINE, 2022, 49
  • [6] A Case of Chronic Eosinophilic Pneumonia Associated With the Use of Weight Loss Combination Medication Naltrexone-Bupropion
    Schuldt, Anastasia
    Najmuddin, Asif
    Sharma, Munish
    Surani, Salim
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [7] The Naltrexone-Bupropion Combination Reduces the Prevalence of the Metabolic Syndrome and Improves Cardiometabolic Markers in At-Risk Subjects
    Erickson, Janelle
    Greenway, Frank
    Dunayevich, Eduardo
    Tollefson, Gary
    OBESITY, 2008, 16 : S139 - S139
  • [8] Contrave, a bupropion and naltrexone combination therapy for the potential treatment of obesity
    Padwal, Raj
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (10) : 1117 - 1125
  • [9] Naltrexone-bupropion combinations do not affect cocaine self-administration in humans*
    Regnier, Sean D.
    Stoops, William W.
    Lile, Joshua A.
    Alcorn III, Joseph L.
    Bolin, B. Levi
    Reynolds, Anna R.
    Hays, Lon R.
    Rayapati, Abner O.
    Rush, Craig R.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2023, 224
  • [10] Treatment with liraglutide or naltrexone-bupropion in patients with genetic obesity: a real-world study
    Welling, Mila S.
    de Groot, Cornelis J.
    Mohseni, Mostafa
    Meeusen, Renate E. H.
    Boon, Mariette R.
    van Haelst, Mieke M.
    van den Akker, Erica L. T.
    van Rossum, Elisabeth F. C.
    ECLINICALMEDICINE, 2024, 74
12345